(via Thenewswire.ca)
September 21, 2016 / TheNewswire / Corporate Update
Kelowna, British Columbia, Canada - September 21, 2016. Marapharm ticker symbols: Canada - CSE:MDM / Germany - FSE:2M0 / United States - OTCQB:MRPHF)
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Marapharm Ventures Inc. (“Marapharm” or the “Company”)
(http://www.marapharm.com) Further to its news release dated June 16,
2016, the Company is pleased to announce it has concluded the
acquisition of a 75% interest in two additional medical marijuana
licenses in Las Vegas, Nevada. The Company currently controls a
provisional grow license in Las Vegas, where it is planning to build a
medical marijuana facility of up to approximately 300,000 square feet.
The plan is to merge all three licenses onto the 7-acre parcel of land
and operate as a campus.
|
|The City of North Las Vegas has approved the special use permits for
all three licenses to be constructed on the land owned by Marapharm
Las Vegas LLC.“Once the campus is complete, we will be one of the
largest producers of Medical Marijuana in Nevada”.
|
|For further information, please refer to the Company’s annual
information form dated July 12, 2016 and filed under the Company’s
profile on SEDAR on July 12, 2016.
|
|About Marapharm Ventures Inc.http://www.marapharm.com/Additional
information on the operations or financial results of Marapharm are
included in reports on file with applicable securities regulatory
authorities and may be accessed through the CSE website
(http://www.thecse.com/) and Sedar website (http://www.sedar.com/)
under the profile for Marapharm Ventures Inc.
|
|FOR FURTHER INFORMATION:info@marapharm.comNeither the CSE, the FSE
nor the OTCQB® has approved nor disapproved the contents of this
press release. Neither the CSE, the FSE nor the OTCQB® accepts
responsibility for the adequacy or accuracy of this
release.Forward-Looking StatementsCertain statements contained in this
news release constitute forward looking statements. The use of any of
the words“anticipate”, “continue”, “estimate”,
“expect”, ‘may”, “will”, “project”, “should”,
‘believe”, and similar expressions are intended to identify
forward-looking statements. These statements involve known and unknown
risks, uncertainties and other factors that may cause actual results
or events to differ materially from those anticipated in such
forward-looking statements are based on reasonable assumption but no
assurance can be given that these expectations will prove to be
correct and the forward-looking statements included in this news
release should not be unduly relied upon.|
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Copyright (c) 2016 TheNewswire - All rights reserved.
